The Healthcare Technology Report is pleased to announce the Top 50 Healthcare Technology CEOs of 2019. An extensive process was run to evaluate the hundreds of CEOs that lead exemplary organizations in the fields of medical devices, biotech, healthcare analytics, healthcare software and other related areas. We gathered data on each nominee’s professional background and assessed them across several key areas including breadth of leadership experience in the healthcare technology industry, level of expertise and domain knowledge in their particular field, depth of their executive team’s experience, and consistency of organizational performance. Congratulations to each of the Top 50 Healthcare Technology CEOs of 2019.
1. Marc Casper
Thermo Fisher Scientific
Marc Casper has been President and CEO of Thermo Fisher Scientific since October 2009. He joined the company in 2001 as President of the Life Sciences sector of Thermo Electron. He was named Senior Vice President in 2003, and in 2005 was given responsibility for all of the company’s operating divisions. After the merger creating Thermo Fisher Scientific in 2006, Marc was named President, Analytical Technologies, and in 2008 was named Chief Operating Officer. Marc began his career at Bain & Company as a strategy consultant and later joined Bain Capital. He received an MBA with high distinction from Harvard University and is a graduate of Wesleyan University, where he received a bachelor’s degree in economics.
2. Alex Gorsky
Johnson & Johnson
Alex Gorsky is Chairman and CEO of Johnson & Johnson, a position which he has held since 2012. He is the seventh person to serve in the joint position since the Company went public in 1944. Alex began his Johnson & Johnson career as a sales representative with Janssen Pharmaceutica in 1988. Over the next 15 years, he advanced through positions of increasing responsibility in sales, marketing, and management. In 2001, Alex was appointed President of Janssen, and in 2003, he was promoted to Company Group Chairman of Johnson & Johnson’s pharmaceuticals business for the regions of Europe, the Middle East and Africa. Between 2004 and 2008, Alex led Novartis’ pharmaceuticals business in North America, later returning to Johnson & Johnson as a key senior leader. He earned his undergraduate degree from West Point and an MBA from The Wharton School of Business.
3. Anne Wojcicki
Anne Wojcicki is the cofounder and CEO of 23andMe. She founded the Company in 2006 after leaving a career in investing with Passport Capital and Investor AB. 23andMe received a $300 million investment from GlaxoSmithKline in July 2018. Since then, the Company has won approval for ten genetic risk tests, including ones for Alzheimer's, Parkinson's and celiac disease, and has expanded into drug discovery. Anne attended Yale University where she was a competitive ice skater and played on the women’s ice hockey team. She earned a bachelor’s in biology; she also conducted molecular biology research at the National Institutes of Health and the University of California, San Diego.
4. Francis deSouza
Francis deSouza was appointed President and CEO of Illumina in 2016. He initially joined the Company as President in 2013. Previously, Francis served as President of Products and Services at Symantec Corporation, where he was responsible for driving the vision for the company’s market-leading portfolio and served in a variety of executive roles. He joined Symantec through the acquisition of IMlogic, where he was co-founder and CEO. Prior to joining IMlogic, Francis was co-founder and CEO of Flash Communications, a provider of corporate instant messaging that was acquired by Microsoft. Following the acquisition, he joined Microsoft and led the team responsible for the development of the company’s enterprise real-time collaboration offerings. Francis is a member of the board of directors for The Walt Disney Company.
5. Colin Hill
Colin Hill co-founded GNS Healthcare in 2000 and has since served as Chairman and CEO.
He sits on board of Biotelemetry Inc., the leading mobile health information company, and PPD, a leading global contract research organization. He is also a founding board member of TMed (Transforming Medicine: The Elizabeth Kauffman Institute), a non-profit foundation (501c3) dedicated to the advancement of personalized medicine. In 2016, he was appointed by Massachusetts Governor Charlie Baker to the Massachusetts Digital Health Council. Colin was a founding member of the Board of Directors of AesRx, a biopharmaceutical company dedicated to the development of new treatments for sickle cell disease (acquired by Baxter in 2014). He graduated from Virginia Tech with a degree in physics and earned master’s degrees in physics from McGill University and Cornell University.
6. Oliver Kharraz
Oliver Kharraz, MD, is CEO and founder of Zocdoc. Prior to Zocdoc, Oliver was an Associate Principal at the global management consulting firm McKinsey & Company. During his seven-year tenure at McKinsey, he developed and implemented new patient utilization models for the national health services of a number of governments and major hospital chains. In 1994, Oliver built and sold his first business – a forerunner of early internet software. He later became a resident doctor at the clinic of Ludwig Maximilian University in Munich, where he earned an MD and a Doctorate in Neuroscience. Oliver also has a master’s degree in Philosophy from the Jesuit College of Philosophy in Munich. He is a member of the Council on Foreign Relations.
7. Judy Faulkner
Judy Faulkner is the CEO and founder of Epic Systems, a healthcare software company located in Wisconsin. She founded the Company in 1979, with the original name of Human Services Computing, with $70,000 in backing from friends and family. Since then, the Company has never raised venture capital or private equity capital. Faulkner has stated she has no intentions of taking the company public. She is reported to be one of the wealthiest self-made women in America with an estimated net worth of $3.5 billion. Epic Systems now holds the medical records of over 200 million people. She and her family currently own 43% of the Company. Faulkner received a bachelor's degree in mathematics from Dickinson College and a master's degree in computer science from the University of Wisconsin–Madison.
8. Patrick Soon-Shiong
Dr. Patrick Soon-Shiong has served as CEO and Chairman since the formation of NantHealth in July 2010. Previously, he invented and developed Abraxane, the nation’s first FDA-approved protein nanoparticle albumin-bound delivery technology for the treatment of cancer. Abraxane was approved by the FDA for metastatic breast cancer in 2005, lung cancer in 2012, and pancreatic cancer in 2013. Abraxane is now approved in many countries across the globe with sales of approximately $1.0 billion. From 1997 to 2010, Dr. Soon-Shiong served as founder, Chairman and CEO of two global pharmaceutical companies, American Pharmaceutical Partners (sold to Fresenius SE for $5.6 billion in 2008) and Abraxis BioScience (sold to Celgene Corporation for $3.6 billion in 2010).
9. Kevin Lobo
Kevin Lobo is Chairman and CEO of Stryker. He joined the Company in 2011, and had previously been Group President of Orthopaedics. Previously, Kevin spent eight years at Johnson & Johnson where his roles included CFO of McNeil Consumer Healthcare and Ortho Women’s Health & Urology, President of J&J Medical Products Canada and President of Ethicon Endo Surgery. Earlier in his career he held finance positions with KPMG, Unilever and Kraft Canada. Kevin serves on the Board of Directors for Parker Hannifin Corporation, the global leader in motion and control technologies. He is also a board member of the Advanced Medical Technology Association (AdvaMed), the Business Leaders for Michigan and United Way for Kalamazoo/Battle Creek regions, and is a member of the Business Roundtable.
10. Frans van Houten
Frans van Houten is CEO and Chairman of Royal Philips, a position he has held since April 2011. He first joined Philips in 1986 and has held multiple global leadership positions across the company on three continents, including the role of co-CEO of the Consumer Electronics division. Frans drives Philips’ strategic agenda to provide healthcare technology solutions in support of seamless, patient-centered care across the health continuum, starting with healthy living and prevention, precision diagnosis and personalized treatment, to care in the home – where the cycle to healthy living begins again. As a seasoned business leader, Frans served as Co-Chair at the World Economic Forum in Davos in 2017. He was appointed a member of the Board of Directors of Novartis in 2017.
11. Mike Mahoney
Mike Mahoney is Chairman and CEO of Boston Scientific. Previously, he was the Worldwide Chairman of the medical devices and diagnostics division of Johnson & Johnson. He has more than 25 years of experience in key senior leadership positions of multi-billion dollar enterprises in the fields of medical devices, capital equipment and healthcare IT. Mike earned his undergraduate degree in Finance from the University of Iowa and his MBA from Wake Forest University. He serves on the Board of Directors of Baxter International and on the Board of Governors of Boston College CEO Club. He is also a member of the American Heart Association CEO roundtable.
12. Jean-Jacques Bienaime
Jean-Jacques Bienaime is currently the Chairman and CEO at BioMarin. He joined the company in May 2005 as CEO and member of the board of directors, bringing with him over 25 years of experience in the biotechnology and pharmaceutical industries. Under his leadership, the market capitalization of BioMarin went from around $450 million in May 2005 to approximately $16 billion in the summer of 2016. From November 2002 to April 2005, Jean-Jacques served as Chairman, CEO, and President of Genencor, a biotechnology company focused on industrial bioproducts and targeted cancer biotherapeutics. He currently serves on the boards of Incyte Corporation and Vital Therapies, which are both biotechnology companies and The Biotech Industry Organization.
13. Omar Ishrak
Omar Ishrak has served as Chairman and CEO of Medtronic since June 2011. In 2014, Omar engineered the acquisition of Covidien, a $10 billion global manufacturer of surgical products and supplies. The acquisition of Covidien was the largest medical technology acquisition in the history of the industry. Omar joined Medtronic from General Electric Company, where he spent 16 years, most recently as President and CEO of GE Healthcare Systems, a $12 billion division of GE Healthcare. Omar sits on the Board of Directors of Intel and the Board of Trustees of the Asia Society. Medtronic is the world’s leading medical technology company, with $30 billion in annual revenue, and operations reaching more than 150 countries worldwide.
14. Jason Gorevic
Jason Gorevic joined Teladoc as CEO in 2009. Previously he was the Chief Marketing and Product Officer and President of WellPoint and before that was Chief Sales and Marketing Officer of BlueCross BlueShield. Jason, a graduate of the University of Pennsylvania, started his career with Oxford Health Plans. He has grown Teladoc at an astounding rate. Since 2015, revenue has gone from $77 million to $123 million to $233 million and to $418 million in each of the subsequent years while steadily holding net income at close to breakeven. Founded in 2002, Teladoc is the nation’s first and largest provider of telehealth services with more than 3 million members nationwide and an average response time of 22 minutes.
15. Kieran Murphy
Kieran Murphy is President and CEO of GE Healthcare. Kieran joined GE Healthcare in 2008 from Whatman, a global supplier of filters and membranes for laboratory research, life sciences and medical diagnostic applications. Previously, Kieran was President and CEO of GE Healthcare Life Sciences. He began his career with Janssen Pharmaceutical, a division of Johnson & Johnson and also held leadership roles with Novartis, ML Laboratories and Innovata, among other companies. GE Healthcare is a business unit of General Electric that provides medical technologies and solutions to the global healthcare industry. It supports customers in over 100 countries with a broad range of services and systems, from diagnostic imaging and healthcare IT to molecular diagnostics and life sciences.
16. Rusty Frantz
Rusty Frantz was appointed President, CEO and Board Director of NextGen Healthcare in 2015. Previously, he spent eight years serving in varying roles with increasing responsibility at CareFusion Corp, a San Diego-based global medical technology. From 2011 until 2015, when CareFusion was acquired by Becton, Dickinson and Company (BD), Frantz served as Senior Vice President and General Manager, Global Dispensing Division. During this time, he spearheaded a transformational medication management strategy across three global brands - Pyxis, Rowa and CareFusion Smartworks - which comprised $1 billion in global revenue. Rusty holds a bachelor’s degree in engineering from the Maine Maritime Academy and a master's of engineering from Stanford University.
17. Brent Shafer
Brent Shafer is Chairman CEO of Cerner, which he joined in 2018. Previously, he was the CEO of Philips North America, where he oversaw a health technology portfolio that included a broad range of solutions and services covering patient monitoring, imaging, clinical informatics, sleep and respiratory care as well as a group of market-leading consumer-oriented brands. Brent was also previously the CEO of the global Philips Home Healthcare Solutions business. Earlier in his career, he served in senior leadership positions at other companies, including GE Medical Systems, Hill-Rom and Hewlett-Packard. He serves on the board of No Barriers USA, a nonprofit that organizes life-changing experiences for youth, veterans and people with disabilities.
18. David Endicott
David Endicott is CEO of Alco. He joined the Company in 2016 as President, Commercial & Innovation, and Chief Operating Officer. Previously, David was President of Hospira Infusion Systems, a Pfizer company, where he led Hospira’s medical device business through a turnaround, carve-out, and eventual sale. Prior to Hospira, David served as a key senior leader and executive committee member of Allergan. He spent more than 25 years with Allergan in leadership roles across Europe, Asia, Latin America, as well as the U.S. He expanded Allergan’s international presence and helped drive growth of new businesses in the areas of ophthalmology, plastic surgery, dermatology and aesthetic medicine. David holds an undergraduate degree in Chemistry from Whitman College and an MBA from the University of Southern California.
19. Joe Almeida
Joe Almeida was named Chairman, President and CEO of Baxter in January 2016. Prior to joining Baxter, Almeida served as Chairman, President and CEO of Covidien from 2012 through 2015 and was named a director of the company in 2011. Joe previously served as President of Covidien's Medical Devices organization. He also served in several leadership roles at Covidien's predecessor, Tyco Healthcare, including President of its worldwide medical device business and Vice President of worldwide manufacturing. Joe began his career as a management consultant at Andersen Consulting (Accenture). He is a member of the board of directors of Walgreens Boots Alliance and Ortho-Clinical Diagnostics, a Carlyle Group Company. He also serves on the board of trustees of Partners in Health.
20. Vincent Forlenza
Vincent Forlenza serves as CEO and Chairman of Becton, Dickinson. Previously, he served as President of Becton, Dickinson and Company from 2009 to 2017. He joined the Company in 1980 and has held leadership positions of increasing responsibility in the United States and Europe. Vincent served as Chief Operating Officer from 2010 to 2011, Executive Vice President from 2006 to 2009, President of BD Biosciences from 2003 to 2006 and Senior Vice President of Technology, Strategy and Development. He has been a Director of Moody's Corp. since April 24, 2018 and serves as Chairman of the Advanced Medical Technology Association (AdvaMed) Board of Directors. Vincent obtained his bachelor’s degree in chemical engineering from Lehigh University and his MBA from Wharton School of Business.
21. Michel Vounatsos
Michel Vounatsos has been CEO and a board member of Biogen since 2017. He originally joined the Company in 2016 as Executive Vice President, Chief Commercial Officer after a 20 year career at Merck. While at Merck, he held leadership positions of increasing responsibility in Europe, China, and the U.S., most recently as President, Primary Care Business Line and Merck Customer Centricity. His role as President encompassed responsibility for Merck’s cardiology-metabolic, general medicine, women’s health and biosimilars groups. Earlier in his career, Michel held management positions at Ciba-Geigy. He received his CSCT certificate in Medicine from the Universite Victor Segalen, Bordeaux II, France, and his MBA from the HEC School of Management in Paris.
22. Clay Siegall
Clay Siegall founded Seattle Genetics in 1998 and today is its President, CEO and Chairman. The Company is known for its pioneering of and continued leadership in antibody-drug conjugates, or ADCs for the treatment of cancer. Since its founding, Seattle Genetics has entered into multiple strategic licenses for its ADC technology with Genentech (Roche), AbbVie, GlaxoSmithKline and Pfizer, that have generated more than $300 million to date. Clay earned a PhD in Genetics from The George Washington University. He has raised nearly $700 million through public and private financings over the course of Seattle Genetics’ history to date. Clay also sits on the boards of Ultragenyx Pharmaceutical, Mirna Therapeutics, and Alder Biopharmaceuticals.
23. David Ricks
Dave Ricks is Chairman and CEO of Eli Lilly and Company. He has worked with the Company for over 20 years, most recently he served as President of Lilly Bio-Medicines from 2012 to 2016. Previously, he was President of Lilly USA, the company’s largest affiliate, from 2009 to 2012 and President and General Manager of Lilly China, operating in one of the world’s fastest-growing emerging markets, from 2008 to 2009. Dave originally joined Lilly in 1996 as a business development associate and held several management roles in the U.S. and Canada with increasing levels of responsibility. He earned a bachelor’s of science degree from Purdue University in 1990 and an MBA from Indiana University in 1996. Dave is president of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
24. Paul Black
Paul Black is the CEO and a director of Allscripts. Prior to joining Allscripts in 2012, Paul spent more than 13 years with Cerner Corporation in various executive positions, retiring as Cerner’s COO in 2007. He started his career with IBM where he spent 12 years in a variety of leadership positions in sales, product marketing and professional services. In Kansas City, Paul spent 16 years as Chairman and as an executive officer of Truman Medical Centers, an academic safety net health system. He currently sits on the boards of Netsmart, the Advancement Board University of Kansas Health System and the Harry S. Truman Presidential Library.
25. Stephen Rusckowski
Steve Rusckowski is Chairman, President and CEO of Quest Diagnostics.
He joined the Company as President and CEO in 2012. Under his leadership, Quest has refocused on its core diagnostic information services business, sold non-core assets, delivered disciplined deployment, including share repurchases and acquisitions, and simplified its organizational structure to better serve customers by removing complexity, speeding decision making and empowering employees. Previously, Stephen was CEO of Philips Healthcare, which became the largest unit of Royal Philips Electronics under his leadership. He joined Philips in 2001 when it acquired the Healthcare Solutions Group he was leading at Hewlett-Packard/Agilent Technologies.
26. Namal Nawana
Smith & Nephew
Namal Nawana became CEO of Smith & Nephew in April 2018, when it was announced he would take over from Olivier Buhoun. Previously, Namal was CEO of the medical diagnostics company Alere until its $8 billion acquisition by Abbott in 2017. And before joining Alere, he held senior leadership roles within Johnson & Johnson in escalating responsibility ultimately becoming Worldwide President of its multi-billion dollar spine franchise. Namal is also a member of the Board of Directors of Hologic, a Nasdaq listed company and Advamed, the Advanced Medical Technology Association. He holds an undergraduate degree in mechanical engineering and a master’s degree in medical science.
27. Andrew Witty
Andrew Witty was named CEO of Optum in 2018. The Company is a global health services leader and part of UnitedHealth Group. Previously, Andrew served as CEO and a director of leading pharmaceutical manufacturer GlaxoSmithKline (GSK) from 2008 to 2017. He joined GSK in 1985, and prior to being named CEO served as president of GSK Europe. Before that, he held a variety of international leadership roles for GSK in markets including Asia-Pacific. Andrew is former chancellor of the University of Nottingham, a British public research university, and serves on the Singapore Economic Development Board International Advisory Committee. He is an advisor to 8VC and Hatteras Venture Partners, as well as to the Bill and Melinda Gates Foundation, and a Non-Executive Director of G1 Therapeutics.
28. Dr. Bernd Montag
Bernd Montag, Ph.D., has been CEO of Siemens Healthineers since February 2015. He joined Siemens in 1995 and held various key positions through the years. In 2004, he assumed overall responsibility for computed tomography, and in 2008, he was named President of the Imaging & Therapy Division, which combined the overall business of diagnostic imaging and image-guided therapies. Bernd completed his studies in Physics at the Friedrich-Alexander-University, Erlangen-Nuremberg, and earned a Ph.D. in theoretical multi-particle physics. Siemens Healthineers is a medical technology company with over 170 years of experience and 18,000 patents globally. The Company has 50,000 employees in over 70 countries.
29. Jon Giacomin
Jon Giacomin is the CEO of the Medical segment at Cardinal Health. During his tenure at Cardinal Health, Jon has held a wide range of leadership positions, including president of U.S. Pharmaceutical Distribution, where he was responsible for the business consolidating pharmaceuticals from hundreds of manufacturers into site-specific deliveries to healthcare points of care. Previously, he served as the executive vice president of Pharmaceutical Operations and senior vice president of Inventory Management for the Healthcare Supply Chain Services segment. Jon joined the company in 2001 as vice president and general manager of its Pharmaceutical Repackaging business. Cardinal Health’s medical segment is a leading provider of medical products and supply chain services to hospitals, laboratories, physician offices, surgery centers and other sites of care across the health care continuum.
30. John Josey, PhD
John Josey, PhD has been CEO and a board member of Peloton Therapeutics since 2013. He joined the Company in 2011 as President and Chief Scientific Officer. Previously, John was Vice President of Discovery Chemistry at Array BioPharma, a company he helped to build from the earliest stages, starting as a member of the founding management team in 1998. His previous experience includes working as a medicinal chemist at Amgen and the Glaxo Research Institute. John received a bachelor’s in Chemistry from Colorado State University, a PhD in Organic Chemistry from The University of Texas at Austin, and an MBA from the University of Colorado. He was a Damon Runyon-Walter Winchell postdoctoral fellow at the California Institute of Technology and is currently an adjunct faculty member of the Department of Biochemistry at UT Southwestern Medical Center.
31. Richard Atkin
Richard Atkin is CEO of Greenway Health. He joined Vista Equity Partners in 2014, and has worked with Vista portfolio companies DealerSocket, EagleView, Finastra, Omnitracs, Solera, and STATS. Prior to his role as an operating principal, Richard was President of Vista Consulting Group from 2014 to 2017, where he helped the organization evolve and scale to support the growth in the Vista portfolio. Previously, Richard was the President and CEO of Sunquest from 2005 to 2014. Greenway Health’s roots go back to 1989 with the founding of Medical Manager. Following several acquisitions and name changes, the company became the present-day Greenway Health after combining with Greenway Medical Technologies in 2013.
32. Tom Langan
Tom Langan became CEO of Practice Fusion in 2015. He originally joined the Company in 2014 as its Chief Commercial Officer. Under his leadership, Practice Fusion has experienced rapid growth and success and leads the industry as the most widely used cloud-based EHR. Previously, Tom held executive positions at Symphony Health Solutions and MediMedia. He holds a bachelor’s from Fordham University. Practice Fusion is used by a community of more than 112,000 monthly active healthcare professionals with over 100 million patient records under management. In 2014, Practice Fusion’s EHR facilitated over 56 million patient visits (approximately 6% of all ambulatory visits in the US) and is the fastest growing EHR in the US.
33. Raul Villar
Raul Villa became CEO of AdvancedMD in 2015. Previously, he was the Company’s President and before that was with ADP for over 21 years, initially joining ADP as a District Manager and eventually rising to Senior Vice President of Sales. The Company is based in South Jordan, Utah and offers cloud-based medical office software to ambulatory medical practices. It supports independent physicians and their staff with a comprehensive suite of solutions including practice management, electronic health records, telemedicine, patient relationship management, business analytics reporting, and physician-performance benchmarking. Raul earned his MBA from the University of Connecticut and his bachelor’s from Bryant University.
34. Andrew Thompson
Proteus Digital Health
Andrew Thompson Founded Proteus Digital Health in 2003. He currently services as President and CEO of the Company, which is enabling a new pharmaceutical category – digital medicines. Proteus has issued more than 450 patents encompassing the tracking of medicines while in the human body. Such tracking is enabled with wearable patches that detects medicines and captures response, mobile applications to support patient care and physician data review, as well as data analytics among other functions. Andrew has been a venture capital investor and entrepreneur in Silicon Valley for 30 years. He earned his MBA from Stanford University and also holds a master’s in Education from Stanford and a master’s in Engineering from Cambridge University.
35. Dan Burton
Dan Burton is CEO of Health Catalyst. He has been with the Company since its earliest days when it was a three-person startup. Today, he leads over 700 employees. Health Catalyst is a healthcare data warehousing and analytics company. Dan is also the co-founder of HB Ventures, the first investor in Health Catalyst. Previously, Dan led the Corporate Strategy Group at Micron Technology. He also spent eight years with Hewlett-Packard in strategy and marketing management roles. Earlier in his career he was an associate consultant with the Boston Consulting Group, where he advised healthcare systems and technology companies. Dan earned his MBA with high distinction from Harvard University and his bachelor’s in economics, magna cum laude, from Bringham Young University.
36. Mike McMullen
Mike McMullen became the third CEO in Agilent Technologies’ history in 2015. He initially joined Hewlett-Packard Co., Agilent's predecessor, in 1984, where he quickly became known as an inspiring leader who could deliver transformative business results. Most recently, Mike was Agilent’s President and Chief Operating Officer. Prior to that, he was President of Agilent's Chemical Analysis Group. Mike is the architect and leader of Agilent's strategy for growth in China. He has championed multiple acquisitions that have strengthened the company's position in growing markets. He earned a bachelor's degree in economics and finance from University of Delaware and an MBA from the Wharton School of Business.
37. Matthew Hawkins
Matthew Hawkins is CEO and a board member of Waystar, which he joined in 2017. Previously, he was President of Sunquest Information Systems, leading its transformation into a global leader in laboratory diagnostic informatics. Prior to Sunquest, Matt was with Vista Equity Partners, serving as President and board member of Greenway Health, CEO and board member of Vitera Healthcare Solutions, and CEO and board member of SirsiDynix. From 2004 to 2007, Matt was Vice President and General Manager of Henry Schein Practice Solutions. Earlier in his career, he was a management consultant for McKinsey & Company. Matt earned his MBA from Harvard University and his bachelor’s degree from Brigham Young University.
38. Ali Diab
Ali Diab founded Collective Health in 2013 and currently serves as the Company’s CEO. Previously, he was the co-founder and CEO of Qwilt Software and before that headed product management and business operations for Google AdMob. He brings more than 15 years of technology startup and executive management experience as well as a strong personal motivation to improve the quality and cost of company-sponsored health care after experiencing a major health problem while employed at a growing technology company. He began his career at Goldman Sachs soon after which he transitioned to co-founding BuildPoint in the early 2000s. Ali also held senior product management roles with Microsoft and Yahoo. He earned his undergraduate degree from Stanford University and his master’s degree from Oxford University.
39. Frank Gotthardt
Frank Gotthardt is Chairman of the Management Board of CompuGroup Medical SE. He built the leading global eHealth company, domiciled in Koblenz, from the very start and has continued to lead and shape it since its founding. Today, 400,000 customers and 4,300 employees worldwide have put their trust in the Company. Frank is the Regional Chairman of the Economic Council of Rhineland-Palatinate and a member of the Federal Executive Board. He privately supports the German bone marrow charity, various development projects and numerous other charitable organizations in the region. He is a sponsor of the long-standing ice hockey club, the Cologne Sharks.
40. Mario Schlosser
Mario Schlosser is the CEO and co-founder of Oscar Health, a consumer-focused health insurer founded in 2012 and headquartered in New York City. Prior to Oscar, Mario was a senior investment associated with Bridgewater Associates, one of the largest hedge funds in the industry. He began his professional career at McKinsey & Company in their Frankfurt, Germany office. Oscar uses technology and personalized service to give members transparency into the healthcare system and empower them to choose quality, affordable care. Oscar offers individual and small group plans and its 2018 coverage areas included New York, California, Texas, New Jersey, Ohio alongside Cleveland Clinic, and Tennessee. Mario earned an MBA from Harvard University.
41. Daniel O’Day
Daniel O’Day joined Gilead in 2019 as CEO of Gilead Sciences, which has more than 11,000 employees around the world. Prior to Gilead, he served as the CEO of Roche Pharmaceuticals. His career at Roche spanned more than three decades, during which he held a number of executive positions in the company’s pharmaceutical and diagnostics divisions in North America, Europe and Asia. During his time at Roche, Daniel engineered the acquisitions of Flatiron Health and Foundation Medicine in 2018. He served as a member of the company’s Corporate Executive Committee, as well as on a number of public, private and non-profit boards, including Genentech. Daniel holds a bachelor’s degree in biology from Georgetown University and an MBA from Columbia University.
42. Paul Kaiser
Paul Kaiser is CEO and a board member of MedeAnalytics, which he joined in 2017. The Company provides enterprise-level data analytics solutions to over 1500 clients in the US and UK, including hospitals, health systems, health plans, state Medicaid programs and more. Previously, Paul served as President of TriZetto Provider Solutions, where he led teams to record setting sales and double digit revenue growth while overseeing all aspects of the business including financial performance, business intelligence, sales and product management. Prior to joining TriZetto, he was the director of sales for Cerner Corporation’s managed services portfolio and directed the launch of Cerner’s global managed services solution.
43. Mike Roman
Mike Roman is the CEO of 3M, a Company he has been with for over 30 years. 3M shares and combines its 46 technology platforms to create differentiated solutions that it brings to market through five business groups: Industrial, Health Care, Safety and Graphics, Electronics and Energy, and Consumer. Before becoming CEO in 2018, Mike was COO and held several other key leadership roles at the Company. In 2014, he assumed leadership of 3M’s largest business group, Industrial, which accounts for one-third of 3M’s global sales. Prior to that, Mike served as chief strategist, where he was instrumental in establishing the company’s future roadmap. He joined 3M in 1988 as a senior design engineer, after five years with the Hughes Aircraft Company.
44. Nat Turner
Nat Turner is co-founder and CEO of Flatiron Health, a healthcare technology and services company focused on accelerating cancer research and improving patient care. Its platform enables cancer researchers and care providers to learn from the experience of every patient. Flatiron partners with over 280 community cancer practices, seven major academic research centers and over 15 of the top therapeutic oncology companies. Previously, Nat was co-founder and CEO of Invite Media, an advertising technology company, which was acquired by Google in 2010. He earned a Bachelor’s degree cum laude in economics with concentrations in entrepreneurship and marketing from The Wharton School of Business.
45. Kurt Graves
Kurt Graves has been Chairman, President and CEO of Intarcia since April 2012, having previously served solely as Executive Chairman of the company since August 2010. Prior to joining Intarcia, Kurt was EVP, Chief Commercial Officer, and Head of Corporate and Strategic Development at Vertex Pharmaceuticals. Before his tenure at Vertex, he spent nearly ten years at Novartis Pharmaceuticals, most recently on the Executive Committee as Global Head of the General Medicines Business Unit & Chief Marketing Officer for the Pharmaceuticals division. In addition to his current responsibility at Intarcia, Kurt serves as Chairman of the Board of Radius Health, Inc., and as a Director at Achillion Pharmaceuticals, and Seres Therapeutics.
46. Stéphane Bancel
Stéphane Bancel has served as Moderna's Chief Executive Officer since October 2011 and as a member of Moderna’s board of directors since March 2011. Previously, he served for five years as CEO of the French diagnostics company bioMérieux SA. From July 2000 to March 2006, he served in various roles at Eli Lilly and Company, including as Managing Director, Belgium and as Executive Director, Global Manufacturing Strategy and Supply Chain. Prior to Lilly, Stéphane served as Asia-Pacific Sales and Marketing Director for bioMérieux. He currently serves on the board of directors of Qiagen N.V. and is a Venture Partner at Flagship Pioneering and a trustee of the Museum of Science in Boston.
47. Hervé Hoppenot
Hervé Hoppenot is President, CEO and Chairman of Incyte. Previously, he was the President of Novartis Oncology, where he was responsible for over $11 billion in global sales and an organization of 8,000 employees across 50 countries. His coverage areas included translational medicine, development, approval, and commercialization. Hervé joined Novartis in 2003, and, in addition to his role as President, served as Chief Commercial Officer, Head of Global Product Strategy & Scientific Development, and Senior Vice President, Head of Global Marketing. His career began in 1983 when he joined Rhone Poulenc, later known as Aventis. He served in several senior roles of increasing responsibility, including Vice President of Oncology and Head of the US Oncology business unit. Hervé holds a diploma from ESSEC Business School.
48. Laurent Vacherot
Laurent Vacherot is CEO of Essilor. He has served as COO of the Company since 2010 and in 2016, he was also named President. Laurent first joined Essilor in 1991 as a Senior Vice President, Business Analysis. From 1998 to 2005 he was President of Essilor Canada and from 2005 to 2007 was President of Essilor of America. He took on the role of CFO in 2007. His first role as COO in 2010 was having full responsibility for the Company’s information and technology department as well as investor relations and operations in Latin America. Laurent is a graduate of the French engineering school Ecole Nationale Supérieure des Télécommunications de Paris.
49. Bryan Hanson
Bryan Hanson was named CEO of Zimmer Biomet in 2017. Founded in 1927 Zimmer Biomet is a global leader in musculoskeletal healthcare. The Company designs, manufactures and markets orthopaedic reconstructive products. Previously, Bryan served on Metronic’s Executive Committee and as EVP and President of Metronic’s Minimally Invasive Therapies Group, where he managed over $9 billion in business. Prior to Medtronic, Bryan held various executive roles including Group President of Covidien’s Medical Devices business and Surgical Solutions Group President. He serves on the board of AmeriCares, an emergency response and global health organization committed to saving lives and building healthier futures for people in crisis.
50. Stephen Mooney
Conifer Health Solutions
Stephen Mooney has served as President and CEO of Conifer Health Solutions since its formation in 2008. He has more than 27 years of revenue cycle management and patient finance experience. Under Sean’s leadership, Conifer Health has evolved from a hospital revenue cycle management provider into a multi-billion-dollar, technology-enabled healthcare services company offering a full range of solutions to help hospitals, health systems and self-insured employers achieve better business outcomes. He began his career at Tenet Healthcare where he held various senior-level positions within the organization. Sean received his bachelor’s degree from Stockton State College and his MBA from Pepperdine University.